Zhang is the CEO at Zyxell Inc undertaking the Research and development of bioreactors, Research on cancer immune evasion and immunotherapy; anticancer drug evaluation; stem cell and immunocyte expansion; molecular mechanism of the tissue construction and the “self-renewal” maintenance of expanding stem cells; clinical application (clinical trials) of expanded hematopoietic stem cells, cancer vaccine, and fast immunoassays. He was a Postdoctoral Research Associate at Baylor College of Medicine.

Luca Roncati, MD-PhD, DMLS, is Associate Editor of the European Journal of Gynaecological Oncology (EJGO), Medical Executive at the University Hospital of Modena, and Adjunct Professor at the University of Modena and Reggio Emilia (Italy). Eponym of the Roncati-Manenti triad and describer of T rex lymphoma, he is the author of more than 250 academic publications, he has taken part in the scientific work of various national and international agencies or research groups, he has organized several conferences of national relevance, he has attended as a speaker at numerous congresses and seminars, he holds the intellectual property of an Italian and international patent for anticancer therapy, and he has obtained various national and supranational awards.

Alexei V. Finkelstein, born 06/16/1947. Graduated with honors from the Moscow Phys.-Tech. (1970). Ph.D. (1976); D.Sc. (1991). Since 1970, member of the Laboratory of Protein Physics (then headed by Prof. O.B. Ptitsyn) at the Institute of Protein Research, Russian Academy of Sciences. Heads this Laboratory since 1999. Professor at the Moscow Lomonosov University since 1998. Soros Professor (2001). Author of ~300 papers, of a book "Protein Physics", published in Russian (7 editions), English (2 editions), Chinese (2 editions), and of a book "Physics of Protein Molecules" (in Russian). Citation index: >11000, Hirsch index: 50. Expertise: protein physics; theory of protein structures, folding and design; structural transitions in proteins and amyloids; antifreeze proteins and ice nucleators, phase transitions; force fields; molecular biology; bioinformatics. Awards from FIRCA, INTAS, CASP, HHMI (3 times), NWO, RSF, Moscow, Soros Professor, etc. State Prize of Russia in Science & Technology (1999). Elected to the Russian Academy of Sciences (2008).

Peifeng Li served for 10 years as a medical researcher at the Max-Delbruck Center for Molecular Medicine in Germany. Currently, Dr. Li is a Professor of Medicine, and the Dean of the Institute for Translational Medicine, College of Medicine, Qingdao University. He is the Director, Key Laboratory of Nucleic Acid Biology in Cardiovascular Disease, Shandong, and the Director, International Research Centre for Non-coding RNAs and Translational Medicine, Qingdao.

Sheng Li, PhD, second-level professor, director of the Institute of Insect Science and Technology, South China Normal University. He is a Yangtze River Scholar, an outstanding "National Outstanding Young Scientist", an outstanding "Hundred Talents Program", a national outstanding scientific and technological worker, and a young and middle-aged expert with outstanding contributions. He graduated from the Department of Biology of Hunan Normal University in 1994, and received a Ph.D. in Zoology from the Shanghai Institute of Entomology, Chinese Academy of Sciences in 2000. He returned to China to work after completing his postdoctoral research at Johns Hopkins University in 2006. He has been engaged in insect science research for more than 20 years and has achieved a series of internationally leading research results in the field of insect development and genetics, especially in the direction of "hormonal and nutritional regulation of insect metamorphosis". He has published 82 SCI papers, including 51 papers as the corresponding author and first author in Annual Review of Entomology, Autophagy, Cell Research, Development and PLoS Genetics, and many papers have been selected as cover papers or as special reviews; 6 patents have been authorized. He has organized and undertaken a number of national-level research tasks such as key, key international cooperation and general projects of the National Natural Science Foundation, 973 projects, 863 projects, and transgenic projects. He has been invited to give keynote speeches and conference reports at major international conferences for many times, and has served as the chairman and group member of international conferences for many times, enjoying important academic reputation at home and abroad. He has been appointed as an editorial board member of Journal of Insect Physiology, Insect Science, Bulletin of Entomological Research, Journal of Insect Science and Acta Entomologica Sinica; he has served as a director of the Entomological Society of China, and the director of the Insect Development and Genetics Professional Committee of the Entomological Society of China, and other academic positions.

Pan Xinghua, PhD, professor, doctoral supervisor, postdoctoral co-supervisor, director of the Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, founder and director of Guangdong Provincial Key Laboratory of Single Cell Technology and Application, and head of the Guangdong Pearl River Scholars Program; concurrently a dual-appointed professor at Nanfang Hospital, Pearl River Hospital, Guangdong Provincial People's Hospital, Shenzhen Bay Laboratory Project PI, and visiting professor at West China School of Medicine, Sichuan University, and Hangzhou Cancer Hospital. Previously, he served as a researcher and project PI in the Department of Genetics at Yale University School of Medicine, and concurrently as a researcher at the Yale Center for Excellence in Genomes, Cancer Center, and Stem Cell Center. He is a member of the Encyclopedia of DNA Elements ( ENCODE ) Project Alliance.